🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to study the combination of nivolumab an...
Status
Active Not Recruiting
Location
Karmanos Cancer Institute
Start Date
2023-05-03
Trial ID
NCT05723055
Treatments Being Tested
The purposed of this research is to study the safety and clinical activity ...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center
Start Date
2021-08-24
Trial ID
NCT04301778
Treatments Being Tested
This is a Phase 2 study to evaluate the efficacy, safety, and tolerability ...
Status
Recruiting
Location
University of Alabama at Birmingham - Children's of Alabama
Start Date
2021-03-04
Trial ID
NCT04710576
Treatments Being Tested
This phase Ib/II trial tests the best dose of axatilimab and effectiveness ...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2024-08-02
Trial ID
NCT06523556
The goal of this clinical research study is to find the best dose of the dr...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2025-08-13
Trial ID
NCT06959537
Treatments Being Tested
The study will evaluate the efficacy and safety of axatilimab in participan...
Status
Active Not Recruiting
Location
Royal Prince Alfred Hospital
Start Date
2023-12-11
Trial ID
NCT06132256
Treatments Being Tested
This phase I/II trial tests the safety, side effects, and effectiveness of ...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2024-05-21
Trial ID
NCT06320405
This phase II trial tests how well axatilimab works in treating patients wi...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2025-08-06
Trial ID
NCT07011810
Treatments Being Tested
Open label, single-arm, prospective therapeutic trial. Pembrolizumab (MK-34...
Status
Not Yet Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2026-06
Trial ID
NCT07015853
Treatments Being Tested
A Phase 1 dose escalation study to determine if axatilimab as monotherapy a...
Status
Completed
Location
Honor Health
Start Date
2017-09-01
Trial ID
NCT03238027
Treatments Being Tested